Earlier antipsychotics all work by directly regulating dopamine, a vital brain-cell-signaling chemical that can cause ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

The following is a summary of “Analysis of the Incidence and Outcomes of Breast Cancer in Women with Schizophrenia,” published in the November 2024 issue of Surgery by Den et al. Worldwide, breast ...

The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.

DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an ...

Police cells should be for people who have committed a crime, not for those in desperate need of medical help, writes health ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular ...

Recently, a joint research team from Korea University and Yonsei University announced that women with schizophrenia have a ...

Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...

Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...